Navigation Links
New protocol developed to decontaminate human fetal tissues used for cell transplantation
Date:7/22/2013

Putnam Valley, NY. -- The use of central nervous system fetal tissues derived from routine elective abortions to provide stem cells for transplantation procedures aimed at restoring damage done by neurodegenerative diseases is an established therapy. However, fetal tissue microbial contaminants have been known to cause brain infections in cell transplantation recipients. Now, a research team from Germany has developed a "washing" technique that decontaminates the fetal tissues from which stem cells are derived.

The study appears as an early e-publication for the journal Cell Transplantation, and is now freely available on-line at http://www.ingentaconnect.com/content/cog/ct/pre-prints/ct1020piroth.

"Fetal neural tissue transplantation has become a potential treatment option for patients suffering from neurodegenerative diseases such as Parkinson's disease (PD) and Huntington's disease (HD)," explained study co-author Dr. Guido Nikkah of the Department of Neurosurgery, Erlangen University Clinic, Erlangen, Germany. "However, in Europe neural transplantation of fetal tissue must be performed in accordance with guidelines on "Good Manufacturing Processes," which means that aspects of microbiological safety have to be investigated in detail."

According to the researchers, aborted fetal human tissues carry the risk of bacterial contamination from the abortion process and this is the contributing factor to the subsequent risk of infection to cell recipients. The researchers noted that prior to their study it was not clear whether fetal tissue contamination, or subsequent surgical contamination during cell transplantation normally had the greatest impact as potential contributing factors to microbial infection in hosts.

Their study revealed a wide range of microbial contamination in fetal tissues that could cause infections. 47.7 % of the fetal tissues they sampled were positive for microbial infection. They also found that the risk of bacterial infection was higher than the risk of fungal infection.

To prevent microbial infection in cell transplantation hosts, the researchers developed and tested a microbial "washing" technique. In laboratory tests using rats as transplantation hosts, the technique has been shown to eliminate microbial contamination. Based on the technique's success in decontaminating fetal tissue cells transplanted into laboratory animals, the washing technique was subsequently used in clinical practice.

"To date, more than 350 PD and approximately 100 HD patients have received primary fetal grafts, and so far no contamination has been reported," said Dr. Nikkah.

The researchers noted that although the risk of infection is very low after their procedure, they still recommend antibiotic prophylaxis.

"Detection of a relevant microbial contamination within the narrow time-window prior to transplantation remains difficult," concluded the authors. "While contamination of the transportation fluid is not an exclusion criterion for tissue transplantation, detection of contamination after washing steps is critical."

"The potentially deleterious impact of microbial contamination on the use of cells or tissues for transplantation is an important health factor that cannot be ignored." said Dr. Shinn-Zong Lin, professor of Neurosurgery and superintendent at the China Medical University Hospital, Beigang, Taiwan. "Procedures to reduce the likelihood of contamination such as that described within this paper are therefore of great importance."


'/>"/>

Contact: Robert Miranda
cogcomm@aol.com
Cell Transplantation Center of Excellence for Aging and Brain Repair
Source:Eurekalert

Related biology news :

1. Lower dosage CT-guided lung biopsy protocol maintains quality, minimizes exposure
2. New protocol recommendations for measuring soil organic carbon sequestration
3. NYSCF scientists develop new protocol to ready induced pluripotent stem cell clinical application
4. JISC Collections purchases SpringerProtocols
5. Mini-CT scanner developed as a teaching tool
6. Blossom end rot plummets in Purdue-developed transgenic tomato
7. The first chemical circuit developed
8. Grassroots approach to conservation developed
9. Composite nanofibers developed by Penn scientists next chapter in orthopaedic biomaterials
10. Electronic nose prototype developed
11. New long-term antimicrobial catheter developed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/9/2016)... Paris Police Prefecture ... solution to ensure the safety of people and operations in ... major tournament Teleste, an international technology group specialised ... today that its video security solution will be utilised by ... public safety across the country. The system roll-out is scheduled ...
(Date:6/2/2016)... The Weather Company , an IBM Business (NYSE: IBM ... which consumers will be able to interact with IBM Watson ... or text and receive relevant information about the product or ... long sought an advertising solution that can create a one-to-one ... valuable; and can scale across millions of interactions and touchpoints. ...
(Date:5/20/2016)... -- VoiceIt is excited to announce its new marketing ... working together, VoiceIt and VoicePass will offer an ... slightly different approaches to voice biometrics, collaboration between ... Both companies ... "This marketing and technology partnership allows VoiceIt ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. ... test has received AOAC Research Institute approval 061601. , “This is another AOAC-RI ... stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate ...
(Date:6/23/2016)... OTTAWA, ON (PRWEB) , ... June 23, 2016 , ... ... former DNA Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA ... joining the STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. ...
(Date:6/23/2016)... , June 23, 2016 On Wednesday, ... at 4,833.32, down 0.22%; the Dow Jones Industrial Average edged ... closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on ... ), Nektar Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals ... (NASDAQ: BIND ). Learn more about these stocks ...
(Date:6/23/2016)... , June 23, 2016 ... research report to its pharmaceuticals section with historic ... details and much more. Complete report ... 151 pages, profiling 15 companies and supported with ... http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . The Global ...
Breaking Biology Technology: